Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 3
2001 2
2002 1
2003 2
2004 3
2005 1
2006 3
2007 2
2008 6
2009 4
2010 1
2011 4
2012 3
2013 2
2014 8
2015 5
2016 5
2017 3
2018 3
2019 6
2020 10
2021 7
2022 12
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Results by year
Filters applied: . Clear all
Page 1
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
Authors' reply.
Naccache JM, Cachanado M, Rousseau A, Nunes H. Naccache JM, et al. Lancet Respir Med. 2022 Jan;10(1):e4. doi: 10.1016/S2213-2600(21)00493-8. Lancet Respir Med. 2022. PMID: 34973213 No abstract available.
[Atypical sarcoidosis].
Bouvry D, Uzunhan Y, Naccache JM, Nunes H, Brillet PY, Valeyre D. Bouvry D, et al. Among authors: naccache jm. Rev Med Interne. 2008 Jan;29(1):46-53. doi: 10.1016/j.revmed.2007.10.005. Epub 2007 Oct 30. Rev Med Interne. 2008. PMID: 18054125 Review. French.
[Thoracic sarcoidosis].
Nunes H, Uzunhan Y, Freynet O, Naccache JM, Bouvry D, Brillet PY, Valeyre D. Nunes H, et al. Among authors: naccache jm. Presse Med. 2010 Jan;39(1):93-106. doi: 10.1016/j.lpm.2009.10.010. Epub 2009 Dec 2. Presse Med. 2010. PMID: 19959325 French.
Massive Splenomegaly Indicating Sarcoidosis.
Bachmeyer C, Fayand A, Georgin-Lavialle S, Fedida B, Naccache JM, Lionnet F, Amiot X. Bachmeyer C, et al. Among authors: naccache jm. Am J Med. 2017 Apr;130(4):e141-e142. doi: 10.1016/j.amjmed.2016.11.033. Epub 2017 Jan 31. Am J Med. 2017. PMID: 28159183 No abstract available.
Up-to-date in pulmonary and extrapulmonary sarcoidosis.
Valeyre D, Uzunhan Y, Bouvry D, Naccache JM, Nunes H. Valeyre D, et al. Among authors: naccache jm. Acta Clin Belg. 2008 Nov-Dec;63(6):408-13. doi: 10.1179/acb.2008.084. Acta Clin Belg. 2008. PMID: 19170359 Review.
Lung cancer and interstitial lung disease: a literature review.
Naccache JM, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, Cadranel J. Naccache JM, et al. J Thorac Dis. 2018 Jun;10(6):3829-3844. doi: 10.21037/jtd.2018.05.75. J Thorac Dis. 2018. PMID: 30069384 Free PMC article. Review.
Exposure to inorganic particles in paediatric sarcoidosis: the PEDIASARC study.
Nathan N, Montagne ME, Macchi O, Rosental PA, Chauveau S, Jeny F, Sesé L, Abou Taam R, Brocvielle M, Brouard J, Catinon M, Chapelon-Abric C, Cohen-Aubart F, Delacourt C, Delestrain C, Deschildre A, Dossier A, Epaud R, Haroche J, Houdouin V, Israel-Biet D, Juvin K, Le Jeune S, Lionnet F, Meinzer U, Mittaine M, Nunes H, Mattioni S, Naccache JM, Odièvre MH, Vincent M, Clement A, Valeyre D, Cavalin C; French Sarcoidosis Group and the Silicosis Research Group. Nathan N, et al. Among authors: naccache jm. Thorax. 2022 Apr;77(4):404-407. doi: 10.1136/thoraxjnl-2021-217870. Epub 2021 Oct 21. Thorax. 2022. PMID: 34675126
[Interstitial lung diseases in sarcoidosis].
Bouvry D, Naccache JM, Valeyre D. Bouvry D, et al. Among authors: naccache jm. Rev Prat. 2007 Dec 31;57(20):2258-65. Rev Prat. 2007. PMID: 18320746 Review. French.
Pulmonary malignancies in the immunocompromised patient.
Cadranel J, Naccache J, Wislez M, Mayaud C. Cadranel J, et al. Among authors: naccache j. Respiration. 1999;66(4):289-309. doi: 10.1159/000029397. Respiration. 1999. PMID: 10461078 Review.
83 results